Abstract:Abstract Background Clinical prediction models are widely used to guide medical advice and therapeutic interventions. Asthma is one of the most common chronic diseases globally and is characterised by acute deteriorations. These exacerbations are largely preventable, so there is interest in using clinical prediction models in this area. The objective of this review was to identify studies which have developed such models, determine whether consistent and appropriate methodology was used and whether statistically reliable prognostic models exist. Methods We searched online databases MEDLINE (1948 onwards), CINAHL Plus (1937 onwards), The Cochrane Library, Web of Science (1898 onwards) and ClinicalTrials.gov , using index terms relating to asthma and prognosis. Data was extracted and assessment of quality was based on GRADE and an early version of PROBAST (Prediction study Risk of Bias Assessment Tool). A meta-analysis of the discrimination and calibration measures was carried out to determine overall performance across models. Results Ten unique prognostic models were identified. GRADE identified moderate risk of bias in two of the studies, but more detailed quality assessment via PROBAST highlighted that most models were developed using highly selected and small datasets, incompletely recorded predictors and outcomes, and incomplete methodology. None of the identified models modelled recurrent exacerbations, instead favouring either presence/absence of an event, or time to first or specified event. Preferred methodologies were logistic regression and Cox proportional hazards regression. The overall pooled c-statistic was 0.77 (95% confidence interval 0.73 to 0.80), though individually some models performed no better than chance. The meta-analysis had an I 2 value of 99.75% indicating a high amount of heterogeneity between studies. The majority of studies were small and did not include internal or external validation, therefore the individual performance measures are likely to be optimistic. Conclusions Current prognostic models for asthma exacerbations are heterogeneous in methodology, but reported c-statistics suggest a clinically useful model could be created. Studies were consistent in lacking robust validation and in not modelling serial events. Further research is required with respect to incorporating recurrent events, and to externally validate tools in large representative populations to demonstrate the generalizability of published results.

Past asthma exacerbation in children predicting future exacerbation: a systematic review

Exacerbation history and blood eosinophil count prior to diagnosis of COPD and risk of subsequent exacerbations

A systematic review of methodology used in the development of prediction models for future asthma exacerbation

Pediatric Asthma Exacerbations – 14 Day ED Return Visit Risk Factors

Risk Factors Predicting Severe Asthma Exacerbations in Adult Asthmatics: A Real-World Clinical Evidence

Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study

The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology

Exacerbation history, severity of dyspnoea and maintenance treatment predicts risk of future exacerbations in patients with COPD in the general population

Risk factors for asthma-related hospital and intensive care admissions in children, adolescents and adults: a cohort study using primary and secondary care data

Risk of exacerbation and mortality in asthma - a 10-year retrospective financial database analysis

Primary health care utilization and hospital readmission in children with asthma: a multi-site linked data cohort study

Management of asthma exacerbations in the paediatric population: a systematic review

Adverse respiratory outcomes amongst patients with resolved asthma: matched retrospective cohort study

Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study

REDUCED BRONCHODILATOR REVERSIBILITY CORRELATES WITH SEVERE ASTHMA AND MORE EXACERBATIONS: A PROSPECTIVE 12‐MONTH COHORT STUDY IN A REAL‐WORLD SETTING

Understanding the Clinical Implications of Individual Patient Characteristics and Treatment Choice on the Risk of Exacerbation in Asthma Patients with Moderate-Severe Symptoms

Chronic comorbid conditions and asthma exacerbation occurrence in a general population sample

At-risk children with asthma (ARC): a systematic review

Airway IL-1β and Systemic Inflammation As Predictors of Future Exacerbation Risk in Asthma and COPD.

VARIABILITY OF TOTAL IGE CORRELATES WITH THE ANNUAL SEVERE ASTHMA EXACERBATIONS: A PROSPECTIVE COHORT STUDY IN REAL‐WORLD SETTING

Persistent Airflow Limitation Prediction and Risk Factor Analysis Among Asthmatic Children: A Retrospective Cohort Study